Meitheal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MEITHEAL
MEITHEAL has eighty-two approved drugs.
There are three US patents protecting MEITHEAL drugs.
Summary for Meitheal
| US Patents: | 3 |
| Tradenames: | 69 |
| Ingredients: | 68 |
| NDAs: | 82 |
Drugs and US Patents for Meitheal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meitheal | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 215860-001 | Aug 29, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meitheal | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 204843-001 | Jan 18, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meitheal | LEVOLEUCOVORIN CALCIUM | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 211002-002 | Aug 16, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Meitheal | EPOPROSTENOL SODIUM | epoprostenol sodium | INJECTABLE;INJECTION | 078396-001 | Apr 23, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MEITHEAL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Meitheal Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 102597622 | ⤷ Start Trial |
| New Zealand | 759953 | ⤷ Start Trial |
| Israel | 271045 | ⤷ Start Trial |
| South Korea | 20200069262 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Meitheal Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2435024 | SPC/GB21/029 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: A COMBINATION OF FORMOTEROL, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, GLYCOPYRROLATE, INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ESTERS AND SOLVATES THEREOF, AND BUDESONIDE INCLUDING PHARMACEUTICALLY ACCEPTABLE SALTS, ES; REGISTERED: UK EU/1/20/1498 (NI) 20201210; UK PLGB 17901/0352-001 20201210 |
| 1189916 | 2011C/004 | Belgium | ⤷ Start Trial | PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906 |
| 2785706 | 122020000046 | Germany | ⤷ Start Trial | PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316 |
| 1115417 | SZ 22/2006 | Austria | ⤷ Start Trial | PRODUCT NAME: DAPTOMYCIN |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
